Eli Lil­ly's David Ricks snared $24M pay pack­age in a year tur­bo-boost­ed by Covid-19 an­ti­body

Boost­ed by boom­ing sales of its Covid-19 an­ti­body bam­lanivimab, Eli Lil­ly post­ed dou­ble-dig­it growth in 2020 de­spite a more steady show­ing from its lega­cy port­fo­lio. In his fourth year at the helm, CEO David Ricks will tout 2020 as a win — par­tic­u­lar­ly for his pock­et­book.

Ricks se­cured $23.7 mil­lion in pay in 2020, a rough­ly 11% bump from the pre­vi­ous year, the In­di­anapo­lis drug­mak­er dis­closed in a proxy fil­ing with the SEC.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER